{"key":"op_283_IT","page":{"url":"https://ua.bookimed.com/clinics/country=italy/procedure=immunotherapy/","procedure":{"id":283,"slug":"immunotherapy","name":"Імунотерапія","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":127,"iso":"IT","name":"Італія"},"currency":"USD","data_date":"2026-10-01"},"pages":{"clinics_url":"https://ua.bookimed.com/clinics/country=italy/procedure=immunotherapy/","cost_url":"https://ua.bookimed.com/clinics/country=italy/procedure=immunotherapy/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":6500,"to":13000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":15000,"to":42000},"uk":{"from":60000,"to":100000},"by_technique":[{"technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","technique_id":"pd-1-inhibitor-infusion","price_from":6500,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","technique_id":"pd-l1-inhibitor-infusion","price_from":7500,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","technique_id":"ctla-4-inhibitor-combination","price_from":11000,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Мілан","from":4500}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":2600,"to":5200},{"country_iso":"FR","from":6500,"to":13000},{"country_iso":"GB","from":60000,"to":100000},{"country_iso":"US","from":15000,"to":42000},{"country_iso":"IL","from":3500,"to":12500},{"country_iso":"TR","from":2500,"to":3500},{"country_iso":"MX","from":5500,"to":12000},{"country_iso":"DE","from":12000,"to":24000},{"country_iso":"CA","from":4800,"to":8800},{"country_iso":"AE","from":9000,"to":21000},{"country_iso":"TH","from":5900,"to":13000},{"country_iso":"PL","from":4500,"to":11000},{"country_iso":"KR","from":9000,"to":20000},{"country_iso":"CZ","from":18000,"to":32000},{"country_iso":"AT","from":9000,"to":19000},{"country_iso":"ES","from":3500,"to":18000},{"country_iso":"CN","from":3000,"to":14000},{"country_iso":"AU","from":14000,"to":28000},{"country_iso":"IN","from":6500,"to":12500},{"country_iso":"MY","from":9000,"to":20000},{"country_iso":"VN","from":6500,"to":14000},{"country_iso":"BR","from":6500,"to":12000},{"country_iso":"EG","from":1600,"to":5800}],"base_country":"US","base_is_fallback":false},"savings":{"pct":57,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":2,"items":[{"id":303,"name":"San Raffaele","city":"Milan","rating":4.6,"reviews_count":71,"accreditations":["Scientific Institute for Research and Healthcare Accrediatation","World's Best Hospitals 2021 by Newsweek"],"rank":1,"has_procedure":true,"why_ranked":"Multidisciplinary team including immunologists and oncologists. Specializes in personalized immunotherapy plans, including CAR T-cell therapy. Clinic performs over 52,000 operations annually.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":298,"name":"San Donato Hospital","city":"Milan","rating":4.8,"reviews_count":55,"accreditations":["Scientific Institute for Research and Healthcare Accrediatation","World's Best Hospitals 2021 by Newsweek"],"rank":2,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":{"status":"missing","reason":"not_collected"},"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":353,"slug":"milan","name":"Мілан","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":4500,"profile":{"city_type":"Capital and largest city of Lombardy","access":["Malpensa Airport (MXP), 49 km from Milan","Linate Airport (LIN), 7 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Milan","https://en.wikipedia.org/wiki/Milan_Malpensa_Airport","https://en.wikipedia.org/wiki/Linate_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Melanoma","Non-small cell lung cancer","Renal cell carcinoma","Bladder and urothelial cancer","Head and neck squamous cell cancer","Hodgkin lymphoma","Tumors with high microsatellite instability or mutational burden","Hepatocellular carcinoma"],"contraindications":["Active severe autoimmune disease requiring immunosuppression","Organ transplant recipient","Pregnancy or breastfeeding","Previous severe immune-related reaction to the same drug","Active uncontrolled infection","Chronic systemic steroid therapy above low dose","Hypersensitivity to the drug or its components"],"operation_hours":{"min":1,"max":3,"unit":"hours","qualifier":"Per visit, including check-in, blood tests, 30-60 minute infusion and observation."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":4,"max":35,"unit":"visits","qualifier":"Infusions every 2-6 weeks; length depends on drug, response and tolerance, up to about two years."},"stages":[{"code":"baseline_workup","label":"Baseline testing and imaging","after":{"min":0,"max":0,"unit":"days","qualifier":"Before the first infusion."}},{"code":"first_infusion","label":"First infusion cycle","after":{"min":0,"max":0,"unit":"days","qualifier":"Start of treatment."}},{"code":"maintenance_cycles","label":"Repeat cycles with monitoring","after":{"min":14,"max":42,"unit":"days","qualifier":"Interval between cycles depends on the drug."}},{"code":"response_imaging","label":"Response assessment imaging","after":{"min":60,"max":90,"unit":"days","qualifier":"After about 3-4 cycles."}}],"qualifier":"Repeated infusion cycles continue while the cancer responds and side effects are tolerable."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Infusion is given in a treatment chair and the patient goes home the same day."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":1,"max":3,"unit":"days","qualifier":"Time to normal function after each infusion; depends on fatigue and side effects."},"fly_home_after_days":{"min":0,"max":1,"unit":"days","qualifier":"Same or next day after the first infusion if no reaction; later cycles at home."},"back_to_work_days":{"min":1,"max":3,"unit":"days","qualifier":"Fatigue after each infusion and any immune-related side effects determine return to work."},"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity is possible the next day; intensity depends on fatigue and side effects."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Response is judged on imaging after several cycles; responses can be delayed."},"result_longevity":"Responders may keep durable control for years, while others progress within months. Duration depends on cancer type and response depth.","main_risks":["Fatigue and rash","Immune colitis and diarrhea","Pneumonitis","Hepatitis","Thyroid and other endocrine disorders","Infusion reactions","Rare myocarditis or neurological inflammation"],"complication_rate_pct":{"min":60,"max":80,"unit":"percent","qualifier":"Any immune-related adverse event on single-agent checkpoint inhibitor; grade 3-4 events about 10-20%."},"revision_rate_pct":{"min":10,"max":20,"unit":"percent","qualifier":"Share of patients stopping therapy for immune-related toxicity; varies by drug and tumor."},"success":{"metric":"Objective tumor response rate on imaging","value":30,"horizon":"3-6 months","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"No scars; treatment is an IV infusion without incisions.","pain":"Minimal; only a needle insertion for the intravenous infusion. Mild aches or headache may follow.","preparation":["Confirm diagnosis and biomarker testing (e.g., PD-L1)","Blood tests including liver, kidney and thyroid","Screen for hepatitis, HIV and tuberculosis","Review autoimmune history and current medications","Baseline imaging","Review of steroid and antibiotic use"],"recovery_timeline":[{"phase":"Infusion day","description":"Intravenous infusion lasting 30-60 minutes with observation, then home.","restrictions":["Report fever, breathlessness or rash"]},{"phase":"Days 1-3","description":"Possible mild fatigue, low fever or aches.","restrictions":["Avoid strenuous exertion if tired"]},{"phase":"Weeks 1-6","description":"Window when immune-related side effects such as diarrhea, rash or cough may appear.","restrictions":["Report new symptoms promptly","Do not self-treat diarrhea"]},{"phase":"Ongoing cycles","description":"Repeated infusions every 2-6 weeks with monitoring and periodic imaging.","restrictions":["Avoid live vaccines unless approved by the oncologist"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":42,"unit":"days","qualifier":"Blood tests and symptom review before each next cycle."}},{"purpose":"result_review","requirement":"routine","after":{"min":60,"max":90,"unit":"days","qualifier":"First response imaging after about 3-4 cycles."}},{"purpose":"other","requirement":"conditional","after":{"min":7,"max":365,"unit":"days","qualifier":"Visit for suspected immune-related side effects, any time during or after treatment."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check the qualifications of the clinician who will do the procedure","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"Check the qualifications of the clinician who will be doing the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C2","text":"Check the facilities and standards of the clinic or hospital where treatment will be given","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Are you satisfied with the facilities and standards at the clinic or hospital where you'll be treated?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Make sure you understand the possible complications and side effects of the treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Make sure you understand the possible complications and side effects that could arise from your treatment.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Ask for certification information and the name of the body that certified the surgical setting","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Ask for certification information and the name of the certifying body when assessing a surgical setting.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Patient cannot ask the treating doctor questions about the treatment before it starts","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you been able to ask them questions about your treatment?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F2","text":"Consultation or care offered in a language you do not speak fluently risks misunderstandings","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"Receiving care at a facility where you do not speak the language fluently could lead to misunderstandings about your care.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Pressure to decide quickly, or cheap time-limited offers, is a warning sign","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Feeling short of breath","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Inflammation in the lungs, called pneumonitis, can cause you to feel short of breath and have a bad cough.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"W2","text":"Painful blisters, open sores, or peeling skin","urgency":"contact_clinic","general":false,"source":{"url":"https://www.mdanderson.org/patients-family/diagnosis-treatment/emotional-physical-effects/immunotherapy-treatment-side-effects.html","host":"mdanderson.org","quote":"Contact your care team if you experience painful blisters, open sores, fever or skin that begins to peel.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"W3","text":"Yellowing of skin or eyes","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Liver inflammation, called hepatitis, may cause your skin and eyes to be yellowish.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"W4","text":"Diarrhea","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/diarrhea","host":"cancer.gov","quote":"Tell your doctor or nurse if you are having diarrhea.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Keep showing it to treating staff for up to a year after stopping steroids","document":"steroid alert card","source":{"url":"https://www.worcsacute.nhs.uk/leaflets/iocn-immunotherapy-patient-information-leaflet/","host":"worcsacute.nhs.uk","quote":"Always carry this card and show it to anybody that treats you up to one year after stopping steroids.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T4","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Blood tests","aliases":["Blood tests","blood test"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"},{"field":"initial_assessment_documents","text":"Recent blood test results"},{"field":"packages","text":"Blood tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"PD-L1 test","aliases":["PD-L1 test","PD-L1 testing","PD-L1","biomarker testing (PD-L1)"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm diagnosis and biomarker testing (e.g., PD-L1)"},{"field":"initial_assessment_documents","text":"Biomarker results such as PD-L1 or MSI"}],"what_it_checks":{"text":"Shows whether the tumor has enough target protein to benefit from immunotherapy","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Your test results will show whether you have enough PD-L1 protein in your tumor for you to benefit from a specific immunotherapy medicine.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"type":"case","text":"If you have certain types of cancer","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"You may need a PD-L1 test if you've been diagnosed with certain types of cancer that commonly cause high PD-L1 levels.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"test_prep":{"text":"Preparation depends on how the tissue sample is taken","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Preparations for your test depend on how your tissue sample will be taken.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}},{"id":"T3","name":"Microsatellite instability test","aliases":["Microsatellite instability test","MSI","MSI testing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Biomarker results such as PD-L1 or MSI"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver function tests","liver tests","LFTs"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Kidney function test","aliases":["Kidney function test","kidney function tests","kidney tests","renal function test"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Thyroid function test","aliases":["Thyroid function test","thyroid function tests","thyroid tests","TFTs"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Hepatitis screening test","aliases":["Hepatitis screening test","hepatitis screening","hepatitis"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for hepatitis, HIV and tuberculosis"}],"what_it_checks":{"text":"It identifies hepatitis B or C status to help plan treatment","source":{"url":"https://www.cancer.gov/node/4199/syndication","host":"cancer.gov","quote":"Knowing whether a person has hepatitis B or C may help plan treatment.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"HIV test","aliases":["HIV test","Anti-HIV test","HIV screening"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for hepatitis, HIV and tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"Tuberculosis test","aliases":["Tuberculosis test","TB test","tuberculosis screening"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for hepatitis, HIV and tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"CT scan","aliases":["CT scan","CT","CT imaging","computed tomography scan"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or PET imaging reports"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":2},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":1,"max":3,"unit":"days","qualifier":"Fatigue after each infusion and any immune-related side effects determine return to work."},"complication_rate_pct":{"min":60,"max":80,"unit":"percent","qualifier":"Any immune-related adverse event on single-agent checkpoint inhibitor; grade 3-4 events about 10-20%."},"contraindications":["Active severe autoimmune disease requiring immunosuppression","Organ transplant recipient","Pregnancy or breastfeeding","Previous severe immune-related reaction to the same drug","Active uncontrolled infection","Chronic systemic steroid therapy above low dose","Hypersensitivity to the drug or its components"],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Infusion is given in a treatment chair and the patient goes home the same day."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity is possible the next day; intensity depends on fatigue and side effects."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Response is judged on imaging after several cycles; responses can be delayed."},"fly_home_after_days":{"min":0,"max":1,"unit":"days","qualifier":"Same or next day after the first infusion if no reaction; later cycles at home."},"follow_up_visits":[{"purpose":"assessment","after":{"min":14,"max":42,"unit":"days","qualifier":"Blood tests and symptom review before each next cycle."},"requirement":"routine"},{"purpose":"result_review","after":{"min":60,"max":90,"unit":"days","qualifier":"First response imaging after about 3-4 cycles."},"requirement":"routine"},{"purpose":"other","after":{"min":7,"max":365,"unit":"days","qualifier":"Visit for suspected immune-related side effects, any time during or after treatment."},"requirement":"conditional"}],"indications":["Melanoma","Non-small cell lung cancer","Renal cell carcinoma","Bladder and urothelial cancer","Head and neck squamous cell cancer","Hodgkin lymphoma","Tumors with high microsatellite instability or mutational burden","Hepatocellular carcinoma"],"main_risks":["Fatigue and rash","Immune colitis and diarrhea","Pneumonitis","Hepatitis","Thyroid and other endocrine disorders","Infusion reactions","Rare myocarditis or neurological inflammation"],"pain":"Minimal; only a needle insertion for the intravenous infusion. Mild aches or headache may follow.","preparation":["Confirm diagnosis and biomarker testing (e.g., PD-L1)","Blood tests including liver, kidney and thyroid","Screen for hepatitis, HIV and tuberculosis","Review autoimmune history and current medications","Baseline imaging","Review of steroid and antibiotic use"],"recovery_timeline":[{"phase":"Infusion day","description":"Intravenous infusion lasting 30-60 minutes with observation, then home.","restrictions":["Report fever, breathlessness or rash"]},{"phase":"Days 1-3","description":"Possible mild fatigue, low fever or aches.","restrictions":["Avoid strenuous exertion if tired"]},{"phase":"Weeks 1-6","description":"Window when immune-related side effects such as diarrhea, rash or cough may appear.","restrictions":["Report new symptoms promptly","Do not self-treat diarrhea"]},{"phase":"Ongoing cycles","description":"Repeated infusions every 2-6 weeks with monitoring and periodic imaging.","restrictions":["Avoid live vaccines unless approved by the oncologist"]}],"rehabilitation_days":{"min":1,"max":3,"unit":"days","qualifier":"Time to normal function after each infusion; depends on fatigue and side effects."},"result_longevity":"Responders may keep durable control for years, while others progress within months. Duration depends on cancer type and response depth.","revision_rate_pct":{"min":10,"max":20,"unit":"percent","qualifier":"Share of patients stopping therapy for immune-related toxicity; varies by drug and tumor."},"scars":"No scars; treatment is an IV infusion without incisions.","sessions_or_stages":{"sessions":{"min":4,"max":35,"unit":"visits","qualifier":"Infusions every 2-6 weeks; length depends on drug, response and tolerance, up to about two years."},"stages":[{"code":"baseline_workup","label":"Baseline testing and imaging","after":{"min":0,"max":0,"unit":"days","qualifier":"Before the first infusion."}},{"code":"first_infusion","label":"First infusion cycle","after":{"min":0,"max":0,"unit":"days","qualifier":"Start of treatment."}},{"code":"maintenance_cycles","label":"Repeat cycles with monitoring","after":{"min":14,"max":42,"unit":"days","qualifier":"Interval between cycles depends on the drug."}},{"code":"response_imaging","label":"Response assessment imaging","after":{"min":60,"max":90,"unit":"days","qualifier":"After about 3-4 cycles."}}],"qualifier":"Repeated infusion cycles continue while the cancer responds and side effects are tolerable."},"success":{"metric":"Objective tumor response rate on imaging","value":30,"unit":"percent of patients","horizon":"3-6 months","population":"Adults with advanced melanoma, lung, kidney or bladder cancer on PD-1/PD-L1 inhibitor","evidence_status":"limited"},"techniques":[{"name":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","suits_whom":"Melanoma, lung, kidney and many other solid tumors.","recovery":"Same-day discharge; immune side effects are common and monitored."},{"name":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","suits_whom":"Lung, bladder and liver cancers.","recovery":"Same-day discharge; immune side effects monitored."},{"name":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","suits_whom":"Selected melanoma and kidney cancer patients.","recovery":"Higher side-effect rate; closer monitoring needed."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":1,"max":3,"unit":"hours","qualifier":"Per visit, including check-in, blood tests, 30-60 minute infusion and observation."},"initial_assessment_documents":["Pathology report confirming cancer diagnosis","Biomarker results such as PD-L1 or MSI","Recent CT or PET imaging reports","Recent blood test results","List of current medications and steroid use","Records of previous cancer treatments"],"travel_trips":{"min":1,"max":6,"one_trip_possible":true,"qualifier":"One trip for the first cycle, then treatment continues at home; 4-6 trips if cycles are given abroad."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check the qualifications of the clinician who will do the procedure","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"Check the qualifications of the clinician who will be doing the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C2","text":"Check the facilities and standards of the clinic or hospital where treatment will be given","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Are you satisfied with the facilities and standards at the clinic or hospital where you'll be treated?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Make sure you understand the possible complications and side effects of the treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Make sure you understand the possible complications and side effects that could arise from your treatment.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Ask for certification information and the name of the body that certified the surgical setting","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Ask for certification information and the name of the certifying body when assessing a surgical setting.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Patient cannot ask the treating doctor questions about the treatment before it starts","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you been able to ask them questions about your treatment?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F2","text":"Consultation or care offered in a language you do not speak fluently risks misunderstandings","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"Receiving care at a facility where you do not speak the language fluently could lead to misunderstandings about your care.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Pressure to decide quickly, or cheap time-limited offers, is a warning sign","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Feeling short of breath","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Inflammation in the lungs, called pneumonitis, can cause you to feel short of breath and have a bad cough.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"W2","text":"Painful blisters, open sores, or peeling skin","urgency":"contact_clinic","general":false,"source":{"url":"https://www.mdanderson.org/patients-family/diagnosis-treatment/emotional-physical-effects/immunotherapy-treatment-side-effects.html","host":"mdanderson.org","quote":"Contact your care team if you experience painful blisters, open sores, fever or skin that begins to peel.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"W3","text":"Yellowing of skin or eyes","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Liver inflammation, called hepatitis, may cause your skin and eyes to be yellowish.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"W4","text":"Diarrhea","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/diarrhea","host":"cancer.gov","quote":"Tell your doctor or nurse if you are having diarrhea.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Keep showing it to treating staff for up to a year after stopping steroids","document":"steroid alert card","source":{"url":"https://www.worcsacute.nhs.uk/leaflets/iocn-immunotherapy-patient-information-leaflet/","host":"worcsacute.nhs.uk","quote":"Always carry this card and show it to anybody that treats you up to one year after stopping steroids.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T4","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your team recommends drugs that kill cancer cells","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/chemotherapy","host":"cancer.gov","quote":"Chemotherapy (also called chemo) is a type of cancer treatment that uses drugs to kill cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200},"operation_id":37}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"technique_details":{"status":"ok","items":[{"id":"pd-1-inhibitor-infusion","name":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","how_it_works":{"text":"Blocks checkpoints so immune cells respond more strongly to cancer","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"By blocking them, these drugs allow immune cells to respond more strongly to cancer.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"pd-l1-inhibitor-infusion","name":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","how_it_works":{"text":"Blocks checkpoints so immune cells respond more strongly to cancer","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"By blocking them, these drugs allow immune cells to respond more strongly to cancer.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"ctla-4-inhibitor-combination","name":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","how_it_works":{"text":"These medicines block proteins that restrain immune responses","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Immune checkpoint inhibitors, for example, block proteins that help keep the immune response in check, such as CTLA-4, PD-1, or PD-L1 (a protein that PD-1 attaches to).","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Blood tests","aliases":["Blood tests","blood test"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"},{"field":"initial_assessment_documents","text":"Recent blood test results"},{"field":"packages","text":"Blood tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"PD-L1 test","aliases":["PD-L1 test","PD-L1 testing","PD-L1","biomarker testing (PD-L1)"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm diagnosis and biomarker testing (e.g., PD-L1)"},{"field":"initial_assessment_documents","text":"Biomarker results such as PD-L1 or MSI"}],"what_it_checks":{"text":"Shows whether the tumor has enough target protein to benefit from immunotherapy","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Your test results will show whether you have enough PD-L1 protein in your tumor for you to benefit from a specific immunotherapy medicine.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"type":"case","text":"If you have certain types of cancer","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"You may need a PD-L1 test if you've been diagnosed with certain types of cancer that commonly cause high PD-L1 levels.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"test_prep":{"text":"Preparation depends on how the tissue sample is taken","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Preparations for your test depend on how your tissue sample will be taken.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}},{"id":"T3","name":"Microsatellite instability test","aliases":["Microsatellite instability test","MSI","MSI testing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Biomarker results such as PD-L1 or MSI"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver function tests","liver tests","LFTs"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Kidney function test","aliases":["Kidney function test","kidney function tests","kidney tests","renal function test"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Thyroid function test","aliases":["Thyroid function test","thyroid function tests","thyroid tests","TFTs"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Hepatitis screening test","aliases":["Hepatitis screening test","hepatitis screening","hepatitis"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for hepatitis, HIV and tuberculosis"}],"what_it_checks":{"text":"It identifies hepatitis B or C status to help plan treatment","source":{"url":"https://www.cancer.gov/node/4199/syndication","host":"cancer.gov","quote":"Knowing whether a person has hepatitis B or C may help plan treatment.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"HIV test","aliases":["HIV test","Anti-HIV test","HIV screening"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for hepatitis, HIV and tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"Tuberculosis test","aliases":["Tuberculosis test","TB test","tuberculosis screening"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for hepatitis, HIV and tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"CT scan","aliases":["CT scan","CT","CT imaging","computed tomography scan"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or PET imaging reports"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":2},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}}},"techniques":[{"id":"pd-1-inhibitor-infusion","name":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","how_it_works":{"id":"H1","text":"Blocks checkpoints so immune cells respond more strongly to cancer","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"By blocking them, these drugs allow immune cells to respond more strongly to cancer.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Melanoma, lung, kidney and many other solid tumors.","price_from":6500,"recovery":"Same-day discharge; immune side effects are common and monitored."},{"id":"pd-l1-inhibitor-infusion","name":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","how_it_works":{"id":"H1","text":"Blocks checkpoints so immune cells respond more strongly to cancer","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"By blocking them, these drugs allow immune cells to respond more strongly to cancer.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Lung, bladder and liver cancers.","price_from":7500,"recovery":"Same-day discharge; immune side effects monitored."},{"id":"ctla-4-inhibitor-combination","name":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","how_it_works":{"id":"H1","text":"These medicines block proteins that restrain immune responses","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Immune checkpoint inhibitors, for example, block proteins that help keep the immune response in check, such as CTLA-4, PD-1, or PD-L1 (a protein that PD-1 attaches to).","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Selected melanoma and kidney cancer patients.","price_from":11000,"recovery":"Higher side-effect rate; closer monitoring needed."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your team recommends drugs that kill cancer cells","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/chemotherapy","host":"cancer.gov","quote":"Chemotherapy (also called chemo) is a type of cancer treatment that uses drugs to kill cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200},"operation_id":37}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"UK passport holders can travel to Italy without a visa for up to 90 days in any 180-day period","source":{"url":"https://www.gov.uk/foreign-travel-advice/italy/entry-requirements","host":"gov.uk","quote":"You can travel without a visa to the Schengen area , which includes Italy, for up to 90 days in any 180-day period.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"visa","audience":"us","volatile":true,"text":"U.S. citizens may enter Italy without a visa for up to 90 days for tourist or business purposes","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Italy.html","host":"travel.state.gov","quote":"U.S. citizens may enter Italy for up to 90 days for tourist or business purposes without a visa.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"passport_validity","audience":"uk","volatile":true,"text":"A UK passport must expire at least 3 months after the day you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/italy/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V4","item":"passport_validity","audience":"us","volatile":true,"text":"A U.S. passport must be valid for at least 3 months beyond the period of stay in Italy","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Italy.html","host":"travel.state.gov","quote":"Your passport must be valid for at least 3 months beyond the period of stay.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"medicines","audience":"all","volatile":false,"text":"Foreigners may bring personal medications for 30 days into Italy; bringing a copy of the prescription is recommended","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Italy.html","host":"travel.state.gov","quote":"According to the Ministry of Health, foreigners entering Italy are allowed to bring personal medications for a period of 30 days, but it is recommended that travelers also bring a copy of their prescription with them.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V6","item":"ghic","audience":"uk","volatile":false,"text":"A UK GHIC or EHIC is needed to get medically necessary state healthcare in Italy","source":{"url":"https://www.gov.uk/foreign-travel-advice/italy/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Italy, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V7","item":"hospital_payment","audience":"all","volatile":false,"text":"Private hospitals in Italy usually require advance payment or proof of adequate insurance before admitting a patient","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Italy.html","host":"travel.state.gov","quote":"Private hospitals usually require advance payment or proof of adequate insurance before admitting a patient.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V8","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 118 and ask for an ambulance in Italy","source":{"url":"https://www.gov.uk/foreign-travel-advice/italy/health","host":"gov.uk","quote":"Dial 118 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["austria","azerbaijan","china","czech-republic","dominican-republic","egypt","germany","greece","india","israel","japan","latvia","lithuania","malaysia","mexico","morocco","republic-of-korea","spain","switzerland","thailand","turkey","ukraine","united-arab-emirates","united-kingdom","united-states"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.69,"count":126,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Immunotherapy in Italy typically costs from _op_283_price_from_ to _op_283_price_to_. The total price depends on the drug protocol, cancer type, and the number of treatment cycles required. Patients save approximately _price_percent_discount_% compared to the United States, where the average cost is _price_compare_US_average_. Basic immunotherapy fees usually cover the drug administration and initial specialist consultations.</p>\n\n<ul>\n<li><strong>Immunotherapy with Keytruda (Pembolizumab):</strong> _op_491_price_from_ to _op_491_price_to_ for advanced monoclonal antibody protocols.</li>\n<li><strong>Bacillus Calmette-Guérin (BCG) therapy:</strong> _op_393_price_from_ to _op_393_price_to_ for localized bladder cancer treatments.</li>\n<li><strong>CAR T-cell therapy:</strong> _op_800_price_from_ to _op_800_price_to_ for complex cellular engineering treatments.</li>\n<li><strong>Specialist consultations:</strong> Private oncological visits in Milan typically cost between 15% and 20% more than in regional hubs.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Milan serves as the primary hub for advanced oncology. San Raffaele Hospital treats over 12,000 cancer patients annually. It offers access to PET-MRI and three da Vinci robots. Choosing IRCCS-accredited facilities ensures treatment at top-tier research centers. San Donato Hospital provides packages starting around $2,100. These include on-site hotel stays for international families. This integration reduces logistics costs during long-term therapy cycles.</p>","faq":[{"q":"What types of immunotherapy treatments are available in Italy?","a":"<p>Immunotherapy treatments in Italy include immune checkpoint inhibitors like pembrolizumab and nivolumab, CAR-T cell therapy, and sublingual immunotherapy for allergies. These therapies are regulated by the Italian Medicines Agency and available at accredited centers like San Raffaele in Milan for oncology and hematology.</p> <ul> <li><strong>Checkpoint inhibitors:</strong> Block proteins like PD-1 or CTLA-4 to help T-cells attack solid tumors.</li> <li><strong>CAR-T therapy:</strong> Re-engineers patient T-cells in labs to destroy specific leukemia or lymphoma cells.</li> <li><strong>Biological therapy:</strong> Uses monoclonal antibodies to target antigens and block cancer growth signals.</li> <li><strong>Experimental trials:</strong> Research centers offer clinical trials for dendritic-cell vaccines and combination regimens.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many countries focus solely on cancer, Italy is a leader in diverse immunotherapy applications. San Raffaele in Milan, for instance, performed the first stem cell therapy for severe combined immune deficiency. This highlights Italy's expertise in cellular immunotherapy beyond standard oncology protocols.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the importance of distinguishing between short-term allergy tablets and long-term cancer protocols. Monitoring for delayed side effects like fatigue or liver enzyme changes is a common practical concern during extended treatment cycles.</p>"},{"q":"What is the current status of immunotherapy in Italy's healthcare system?","a":"<p>Immunotherapy is fully integrated into Italy's universal healthcare system and routinely reimbursed for regulatory-approved oncological indications. The Italian Medicines Agency centrally regulates and funds advanced treatments like immune checkpoint inhibitors and cellular therapies within standard public oncology care.</p> <ul> <li><strong>Central regulation:</strong> The Italian Medicines Agency evaluates and approves clinical reimbursement nationwide.</li> <li><strong>Modern framework:</strong> Assessments prioritize comparative effectiveness and budget impact under European Union alignment.</li> <li><strong>Regional delivery:</strong> Practical access and waiting times vary between regional hospital networks.</li> <li><strong>Specialized hubs:</strong> Scientific research institutes like San Raffaele manage complex oncology cases.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Patient volume data highlights a strategic pathway for navigating the public system. Major research hubs in Milan like San Raffaele treat 12,000 cancer patients annually. Choosing an institute with scientific accreditation speeds up access to modern biological therapies.</p> <p><strong>Patient Consensus:</strong> The public healthcare system covers expensive modern therapies at no cost after specialist referral. However, patients advise booking a private consultation with a public-system doctor to bypass regional waiting times.</p>"},{"q":"Are treatments covered under Italy's public healthcare system (SSN)?","a":"<p>Italy's Servizio Sanitario Nazionale (SSN) covers immunotherapy and other expensive cancer treatments for registered residents. These Essential Levels of Care (LEA) are generally free at public or accredited private hospitals. Patients typically only pay a small copayment, known as a ticket, for diagnostic tests or specialist consultations.</p> <ul> <li><strong>Eligibility criteria:</strong> Access requires formal residency status and registration with the national health system.</li> <li><strong>Access pathway:</strong> Patients need a general practitioner referral to consult an oncology specialist.</li> <li><strong>Medication coverage:</strong> Essential drugs, including high-cost Class A therapies, are free or heavily subsidized.</li> <li><strong>Chronic exemptions:</strong> Patients with registered cancer diagnoses are often exempt from standard regional copayments.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While the public system covers high-cost drugs like Keytruda, international patients often choose Milanese centers like San Raffaele for faster access to clinical trials. This clinic achieved the world's first stem cell therapy for severe immune deficiency. Public coverage is medically robust but navigating the paperwork takes time, making private oncology consultations a common way to speed up the initial diagnostic phase.</p> <p><strong>Patient Consensus:</strong> The public system provides excellent care for serious illnesses, though the administrative process can be slow. Residents suggest keeping tax codes and residency papers ready to avoid delays in starting life-saving treatments.</p>"},{"q":"How can a patient access clinical trials for immunotherapy in Italy?","a":"<p>Accessing immunotherapy clinical trials in Italy requires a referral to a certified Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) center. Patients must consult an oncologist to verify eligibility against strict inclusion criteria like PD-L1 expression before searching official registries like the EU Clinical Trials Information System.</p> <ul> <li><strong>Specialist consultation:</strong> Your oncologist must formally refer your records to the trial principal investigator.</li> <li><strong>Registry search:</strong> Use the EU Clinical Trials Register or ClinicalTrials.gov to find Italian sites.</li> <li><strong>IRCCS centers:</strong> Specialized hospitals like San Raffaele in Milan manage advanced cellular therapy protocols.</li> <li><strong>Regulatory oversight:</strong> The Italian Medicines Agency (AIFA) maintains maps of active experimental trial sites.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many search globally, Italy stands out for specialized cellular therapies at IRCCS centers like San Raffaele. Data shows these facilities serve 300,000 patients annually and pioneered the world's first stem cell therapy for immune deficiency. Choosing a center with these specific credentials often indicates a stronger infrastructure for managing complex, late-stage immune reactions.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that access depends on finding the exact National Clinical Trial ID rather than just the drug name. Success often involves checking if the research center accepts outside referrals early in the process.</p>"}],"h2":[{"text":"Яка вартість імунотерапії в Італії?","kind":"content"},{"text":"Переваги та гарантії Bookimed","kind":"content"},{"text":"Ваш особистий лікар-координатор Bookimed","kind":"content"},{"text":"Дізнайтеся про найкращі клініки з імунотерапії у Італії: 2 перевірені клініки та ціни","kind":"content"},{"text":"Огляд процедури Імунотерапія в Італії","kind":"content"},{"text":"Відеоісторії пацієнтів Bookimed","kind":"content"},{"text":"Відгуки про Bookimed: дізнайтеся про реальний досвід пацієнтів","kind":"content"},{"text":"Поділитися цим контентом","kind":"content"},{"text":"Отримати безкоштовну консультацію","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}